Eyepoint Pharmaceuticals
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $11,588 | $10,524 | $9,477 | $11,684 |
Gross Profit | 10,772 | 9,788 | 8,076 | 10,925 |
EBITDA | -40,828 | -32,748 | -30,464 | -28,980 |
EBIT | -41,295 | -33,156 | -30,826 | -29,283 |
Net Income | -41,399 | -29,361 | -30,826 | -29,284 |
Net Change In Cash | 11,588 | 10,524 | 9,477 | 11,684 |
Free Cash Flow | -36,233 | -40,602 | -21,078 | -32,365 |
Cash | 99,704 | 79,830 | 90,769 | 271,013 |
Basic Shares | 56,298 | 54,449 | 53,206 | 52,913 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $43,273 | $46,018 | $41,404 | $36,939 |
Gross Profit | 39,561 | 41,386 | 33,078 | 28,762 |
EBITDA | -129,226 | -69,001 | -96,619 | -50,148 |
EBIT | -130,766 | -69,465 | -99,065 | -52,919 |
Net Income | -130,870 | -70,795 | -124,512 | -63,915 |
Net Change In Cash | 43,273 | 46,018 | 41,404 | 36,939 |
Cost of Revenue | -82,960 | 133,684 | ||
Free Cash Flow | -130,278 | -1,608 | -67,155 | -50,253 |
Cash | 99,704 | 281,263 | 95,633 | 178,593 |
Basic Shares | 56,298 | 38,904 | 37,317 | 28,758 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$0.64 |
2024-09-30 | -$0.54 |
2024-06-30 | -$0.58 |
2024-03-31 | -$0.55 |
